The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

A drug to prevent migraine may start working right away, according to a new study. People taking atogepant were less likely to have a migraine on the first day of taking it compared to those given ...

An oral drug, lasmiditan is a selective serotonin 5-HT1F agonist that Lilly says is distinct from other approved migraine therapies and does not cause constriction of blood vessels.

Pfizer will pay nearly $60 million to settle allegations that Biohaven, a company it acquired, paid kickbacks to healthcare ...

A new drug for chronic migraines could make "a massive difference" if it was available on the NHS in Wales, a former national poet of Wales has said. Gwyneth Lewis, who has up to 21 migraines a ...

The FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms should they feel an attack coming on. Under the brand name Reyvow, Lilly’s ...

A study reveals that Atogepant, a new migraine prevention drug, offers immediate relief from migraines from the first day of use, significantly reducing migraine occurrences and improving the ...

[92] Onabotulinum toxin-A is approved for headache prophylaxis in adults with chronic migraine and has approximately the same rate of improvement. Side effects of PAM drugs should be reviewed ...